LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Protein Patterning: Novel Tool for Studying Sepsis

By LabMedica International staff writers
Posted on 18 Jan 2016
Print article
Image: Graph of mass-spectrometry-based mapping of tissue-specific protein in blood plasma, from the study of sepsis using quantitative targeted proteomics (Photo courtesy of Malmström laboratory, Lund University).
Image: Graph of mass-spectrometry-based mapping of tissue-specific protein in blood plasma, from the study of sepsis using quantitative targeted proteomics (Photo courtesy of Malmström laboratory, Lund University).
In a new approach using quantitative targeted proteomics, researchers have for the first time developed a way to use mass-spectrometry to measure hundreds of organ proteins in a single blood sample. The resulting protein patterns can help determine sepsis severity, which organs have been damaged, and may lead to faster diagnostics.

“We use the blood as a mirror reflecting what happens in the body,” said Johan Malmström biomedical scientist at Lund University (Lund, Sweden), whose brothers, medical intern Erik Malmström (Lund U.) and bioinformatician Lars Malmström University of Zurich (Zurich, Switzerland) are fellow researchers on the study. The team has succeeded to map the majority of all detected proteins from vital organs (e.g., heart, lung, liver, spleen, blood vessels) and have listed which proteins were specific to each organ.

“If you see in a blood sample that the amount of proteins from a specific organ significantly increases, it indicates damage to this organ. The method provides an understanding of the molecular events that take place during the course of a disease, and the possibility, using the same analysis, to study how different organs are affected”, explained Dr. E. Malmström.

Sepsis is a very complicated and precarious condition in which the immune system starts to react erroneously in different ways to the bacterial infection. It is often difficult to diagnose because symptoms (including high breathing rate, fever, rapid pulse, pain, confusion) occur in milder conditions as well. Disease progression can be very fast and become fatal within a few hours. Therefore, there is a great need for faster diagnosis and better understanding of the course of the disease.

Another researcher, Dr. Adam Linder (Lund U.), has begun to develop a diagnostic method based on HBP, a protein emitted from white blood cells and reflects the risk of hypotension. The Malmström group’s study of hundreds of different proteins could eventually be used to select other important proteins that can serve as biomarkers for different aspects of sepsis.

The new method is already an important research tool: “There is so much we don’t know about sepsis. Why do not all patients react the same way—why do some organs suffer the most damage in some patients and not in others? Do different bacteria cause the disease to progress? Can you divide patients into different subgroups, or bacteria, or does each new combination of patients and bacteria lead to a specific form of sepsis?” asked Dr. E. Malmström. The researchers have conducted their studies on animals and are now moving on to human tissue. Through a collaboration with surgeons at Skane University Hospital they have obtained samples of healthy tissue. Protein patterns of these samples can then be compared with the corresponding organ tissues in sepsis patients.

“Protein mapping like this has never been done before. The method can also be applied to other diseases for studying how pathological changes in various organs are reflected in a blood sample,” said Dr. Johan Malmström.

The study, by Malmström E, Kilsgard O, Hauri S, Smeds E, Herwald H, Malmström L, & Malmström J, was published January 6, 2016, in the journal Nature Communications.

Related Links:

Lund University
University of Zurich 


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Piezoelectric Micropump
Disc Pump

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.